T1	Participants 36 64	multicenter study SAKK 40/81
T2	Participants 98 135	curatively resected colorectal cancer
T3	Participants 139 194	Between 1981 and 1987, 533 patients from 9 institutions
T4	Participants 360 382	469 evaluable patients
